Cedlara Study

etermine if an investigational drug reduces symptoms of celiac disease when taken while maintaining a gluten-free diet. CeDLara is recruiting patients 18 years or older who have had a confirmed diagnosis of celiac disease for over six months, are actively experiencing symptoms related to celiac disease, and have followed a gluten-free diet for at least 6 months. Patients must also be willing to maintain a gluten-free diet throughout their participation in the study, which takes about 30 weeks. Learn more about the trial, including details on inclusion and exclusion criteria, here: https://celiac-study.com/